Order Article Reprints

Homicsko K, Dummer R, Hoeller C, Wolchok JD, Hodi FS, Larkin J, Ascierto PA, Atkinson V, Robert C, Postow MA, et al. Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma. Cancers. 2022; 14(9):2300. https://doi.org/10.3390/cancers14092300

Homicsko, Krisztian, Reinhard Dummer, Christoph Hoeller, Jedd D. Wolchok, F. Stephen Hodi, James Larkin, Paolo A. Ascierto, Victoria Atkinson, Caroline Robert, Michael A. Postow, and et al. 2022. "Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma" Cancers 14, no. 9: 2300. https://doi.org/10.3390/cancers14092300

Homicsko, K., Dummer, R., Hoeller, C., Wolchok, J. D., Hodi, F. S., Larkin, J., Ascierto, P. A., Atkinson, V., Robert, C., Postow, M. A., Re, S., Paulucci, D., Dobler, D., & Michielin, O. (2022). Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma. Cancers, 14(9), 2300. https://doi.org/10.3390/cancers14092300